<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03545828</url>
  </required_header>
  <id_info>
    <org_study_id>MAEGIC-01</org_study_id>
    <nct_id>NCT03545828</nct_id>
  </id_info>
  <brief_title>Multi-channel aEEG in Cardiac Arrest Patients With Targeted Temperature Management</brief_title>
  <acronym>MAEGIC</acronym>
  <official_title>Neurological Prognostication Using Multi-channel Amplitude-integrated Electroencephalographic Monitoring in Cardiac Arrest Patients With Targeted Temperature Management</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sang Hoon Oh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul St. Mary's Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to examine the prognostic value of 18 channel amplitude-integrated EEG (aEEG)
      in comatose cardiac arrest patients The study design is a prospective observational study.
      Cardiac arrest patients undergoing targeted temperature management (TTM) will participate in
      the study. Relation of aEEG in each channel with the neurologic outcome at 6 month after
      return of spontaneous circulation (ROSC) will be evaluated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Normal trace was defined as continuous cortical activity on the raw EEG scan; in addition,
      the upper margin of the aEEG scan, referred to as the aEEG maximum, was &gt;10 μ V, and the
      lower margin of the aEEG scan, referred to as the aEEG minimum, was &gt;5 μ V. The Time from
      ROSC to normal trace (TTNT, hours) is predictor of neurological outcome in these patients. We
      will evaluate the prognostic values of TTNTs in all aEEG channels.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">June 30, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>Time to normal trace in each aEEG channel</measure>
    <time_frame>at day 180</time_frame>
    <description>Normal trace was defined as continuous cortical activity on the raw EEG scan; in addition, the upper margin of the aEEG scan, referred to as the aEEG maximum, was &gt;10 μ V, and the lower margin of the aEEG scan, referred to as the aEEG minimum, was &gt;5 μ V. The Time from ROSC to normal trace (TTNT, hours) is predictor of neurological outcome in these patients. We will evaluate the prognostic values of TTNTs in all aEEG channels.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>TTNT threshold for neurologic prognostication in each aEEG channel</measure>
    <time_frame>at day 180</time_frame>
    <description>Using area under the curve (AUC) of each channel aEEG for neurological outcome, we will determine the best TTNT thresholds for good neurological outcome (CPC 1 to 2) in all aEEG channels.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alpha delta ratio of each channel aEEG for good neurological outcome (CPC 1 to 2)</measure>
    <time_frame>at day 180</time_frame>
    <description>The percentage powers in the alpha, theta and delta bands and the ratio of the powers in different frequency bands (i.e., alpha/delta) will be calculated. Finally we will evaluate the prognostic values of these ratios of the different bands.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of prognostic value between aEEG and various predictors</measure>
    <time_frame>at day 180</time_frame>
    <description>We will compare the prognostic performances (i.e., sensitivity, specificity, AUC) for poor neurological outcome (CPC 3 to 5) between EEG and these predictors.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">78</enrollment>
  <condition>Heart Arrest</condition>
  <condition>Targeted Temperature Management</condition>
  <arm_group>
    <arm_group_label>Good neurological outcome</arm_group_label>
    <description>CPC 1 and 2 at 6 month after ROSC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Poor neurological outcome</arm_group_label>
    <description>CPC 3 to 5 at 6 month after ROSC</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Multi-channel aEEG monitoring</intervention_name>
    <description>18 channel aEEG monitoring in comatose TTM-treated patients</description>
    <arm_group_label>Good neurological outcome</arm_group_label>
    <arm_group_label>Poor neurological outcome</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        TTM treated cardiac arrest patients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Comatose cardiac arrest TTM treatment Multi channel aEEG monitoring

        Exclusion Criteria:

        Cerebral origin cardiac arrest Known epilepsy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sang Hoon Oh</last_name>
    <role>Study Director</role>
    <affiliation>Seoul St. Mary's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul St. Mary's hospital</name>
      <address>
        <city>Seoul</city>
        <zip>06591</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>April 22, 2018</study_first_submitted>
  <study_first_submitted_qc>May 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2018</study_first_posted>
  <last_update_submitted>September 24, 2019</last_update_submitted>
  <last_update_submitted_qc>September 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Seoul St. Mary's Hospital</investigator_affiliation>
    <investigator_full_name>Sang Hoon Oh</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

